The report on Insulin Pumps Market by Infinium Global Research analyzes over the period of 2016 to 2022. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Insulin Pumps Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Insulin Pumps Market.
The global market for insulin pumps was valued at around USD 2.3 billion in 2015 and is expected to reach USD 4.3 billion by 2022, growing at a CAGR of around 9.5% during the forecast period of 2016 to 2022. Insulin pumps are portable devices attached to the body that continuously deliver amounts of rapid or short acting insulin through a catheter placed under the skin. These are better alternative to insulin injections as they reduce the need for multiple insulin injections per day and give the user increased ability to control blood glucose levels. Approximately 1 in 1,000 people with diabetes wear an insulin pump. An insulin pump consists of the main pump unit which holds an insulin reservoir which typically holds between 176 and 300 units of insulin. The reservoir is attached to a long, thin piece of tubing with a needle or cannula at one end. The tubing and the bit at the end are called the infusion set. Insulin pump therapy is also referred to as continuous subcutaneous insulin infusion therapy.
Get a Sample Report @ https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/151
Diabetes disease is growing across the globe at an extraordinary pace and has become a serious health issue during the last two decades. It is a major cause of mortality in the age group of 20–79 years. Based on its rapidly increasing incidence, it has been declared a global epidemic by the World Health Organization (WHO). According to the International Diabetes Federation (IDF), the number of diabetic patients reached 415 million in 2015 globally and is expected to reach around 642 million by 2040. According to the IDF, global healthcare expenditures to treat diabetes and its complications was USD 673 billion in 2015, representing 12% of total global healthcare expenditures and is expected to exceed USD 802 billion by 2040.
Companies profiled:
• Animas Corp
• Insulet Corp.
• Medtronic Diabetes
• Roche Insulin Delivery Systems
• SOOIL Development Co. Ltd.
• Tandem Diabetes Care, Inc.
Make an Enquiry @ https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/151
Key topics covered:
1. Scope of the report
2 Executive summary
3 Qualitative analysis
4 Global insulin pumps market, by component, 2015 – 2022
5 Global insulin pump market, by geography, 2015 – 2022
6 Company profiles
Click to View Complete Report @ https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_insulin_pumps_market